Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by PharmAla Biotech

PharmAla Contracts with Partner to Act as US Distributor
From PharmAla Biotech
Via GlobeNewswire
Tickers CSE:MDMA MDXXF
PharmAla to supply STRONG STAR at UT Health San Antonio, with novel dosage form of LaNeo™ MDMA
From PharmAla Biotech
Via GlobeNewswire
Tickers CSE:MDMA MDXXF
PharmAla Signs Advisory Agreement with Mr. Matthew Azrieli
From PharmAla Biotech
Via GlobeNewswire
Tickers CSE:MDMA MDXXF
PharmAla To Supply Merhavim Mental Health Centre Clinical Trial in Exchange for Full Data License, in Partnership with MAPS Israel
From PharmAla Biotech
Via GlobeNewswire
Tickers CSE:MDMA MDXXF
PharmAla to supply Mt. Sinai Hospital with LaNeo MDMA
From PharmAla Biotech
Via GlobeNewswire
Tickers CSE:MDMA MDXXF
PharmAla Launches MDMA Clinical Trial Tool for Researchers
From PharmAla Biotech
Via GlobeNewswire
Tickers CSE:MDMA MDXXF
PharmAla Comments on USFDA Decision regarding MDMA-Assisted Therapy and Announces Patent Granting for ALA-002
From PharmAla Biotech
Via GlobeNewswire
Tickers CSE:MDMA MDXXF
Cortexa Commences Manufacturing GMP LaNeo™ MDMA in Australia
From PharmAla Biotech
Via GlobeNewswire
Tickers CSE:MDMA MDXXF
Patent Allowance Granted for ALA-002 Composition by US Patent and Trademark Office
From PharmAla Biotech
Via GlobeNewswire
Tickers CSE:MDMA MDXXF
Patent Allowance Granted for P-1 Molecule by US Patent and Trademark Office
From PharmAla Biotech
Via GlobeNewswire
Tickers CSE:MDMA MDXXF
Cortexa Leads the World in First Supply of Psilocybin Under the TGA’s Authorized Prescriber Scheme
From PharmAla Biotech
Via GlobeNewswire
Tickers CSE:MDMA MDXXF
PharmAla receives new “MDXXF” ticker from FINRA for OTCQB Listing
From PharmAla Biotech
Via GlobeNewswire
Tickers CSE:MDMA
PharmAla-1 Molecule Receives US Patent Prosecution Highway Acceptance
From PharmAla Biotech
Via GlobeNewswire
Tickers CSE:MDMA PMBHF
PharmAla Begins Trading on OTCQB
From PharmAla Biotech
Via GlobeNewswire
Tickers CSE:MDMA PMBHF
PharmAla Files Patent for Novel MDXX Molecule PharmAla-1
From PharmAla Biotech
Via GlobeNewswire
Tickers CSE:MDMA PMBHF
USFDA Approves LaNeo MDMA for Clinical Trial Use in the United States
From PharmAla Biotech
Via GlobeNewswire
Tickers CSE:MDMA PMBHF
PharmAla Biotech to form Australian Psychedelics Joint Venture with Vitura Health
From PharmAla Biotech
Via GlobeNewswire
Tickers ASX:VIT CSE:MDMA
Australia Allows Prescription of MDMA and Psilocybin in Groundbreaking Regulatory Change
From PharmAla Biotech
Via GlobeNewswire
Tickers CSE:MDMA
Mindset Pharma and PharmAla Biotech Enter into Exclusive Sales Agreement
From PharmAla Biotech
Via GlobeNewswire
Tickers CSE:MDMA CSE:MSET MSSTF
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.